BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 10377188)

  • 21. Modulation of major histocompatibility class II protein expression by varicella-zoster virus.
    Abendroth A; Slobedman B; Lee E; Mellins E; Wallace M; Arvin AM
    J Virol; 2000 Feb; 74(4):1900-7. PubMed ID: 10644363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon Regulatory Factors 1 and 2 Play Different Roles in MHC II Expression Mediated by CIITA in Grass Carp,
    Lu XB; Wang ZX; Liu SB; Zhang XY; Lu LF; Li S; Chen DD; Nie P; Zhang YA
    Front Immunol; 2019; 10():1106. PubMed ID: 31191518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon-gamma signaling in human retinal pigment epithelial cells mediated by STAT1, ICSBP, and IRF-1 transcription factors.
    Li W; Nagineni CN; Hooks JJ; Chepelinsky AB; Egwuagu CE
    Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):976-82. PubMed ID: 10102295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction.
    Chin KC; Mao C; Skinner C; Riley JL; Wright KL; Moreno CS; Stark GR; Boss JM; Ting JP
    Immunity; 1994 Nov; 1(8):687-97. PubMed ID: 7600294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TGF-beta suppression of IFN-gamma-induced class II MHC gene expression does not involve inhibition of phosphorylation of JAK1, JAK2, or signal transducers and activators of transcription, or modification of IFN-gamma enhanced factor X expression.
    Panek RB; Lee YJ; Benveniste EN
    J Immunol; 1995 Jan; 154(2):610-9. PubMed ID: 7814871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High level class II trans-activator induction does not occur with transient activation of the IFN-gamma signaling pathway.
    Eason DD; Blanck G
    J Immunol; 2001 Jan; 166(2):1041-8. PubMed ID: 11145683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A positive regulatory role for suppressor of cytokine signaling 1 in IFN-gamma-induced MHC class II expression in fibroblasts.
    Ilangumaran S; Finan D; La Rose J; Raine J; Silverstein A; De Sepulveda P; Rottapel R
    J Immunol; 2002 Nov; 169(9):5010-20. PubMed ID: 12391216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon-gamma induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells.
    Butticè G; Miller J; Wang L; Smith BD
    Circ Res; 2006 Mar; 98(4):472-9. PubMed ID: 16439692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo.
    Hobart M; Ramassar V; Goes N; Urmson J; Halloran PF
    J Immunol; 1997 May; 158(9):4260-9. PubMed ID: 9126988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MHC class II gene silencing in trophoblast cells is caused by inhibition of CIITA expression.
    Morris AC; Riley JL; Fleming WH; Boss JM
    Am J Reprod Immunol; 1998 Dec; 40(6):385-94. PubMed ID: 9894561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The IFN-gamma-induced transcriptional program of the CIITA gene is inhibited by statins.
    Lee SJ; Qin H; Benveniste EN
    Eur J Immunol; 2008 Aug; 38(8):2325-36. PubMed ID: 18601229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo class II transactivator expression in mice is induced by a non-interferon-gamma mechanism in response to local injury.
    Sims TN; Goes NB; Ramassar V; Urmson J; Halloran PF
    Transplantation; 1997 Dec; 64(12):1657-64. PubMed ID: 9422398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins.
    Broxmeyer HE; Cooper S; Hangoc G; Chang CH
    Exp Hematol; 2006 Aug; 34(8):1078-84. PubMed ID: 16863914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interplay among coactivator-associated arginine methyltransferase 1, CBP, and CIITA in IFN-gamma-inducible MHC-II gene expression.
    Zika E; Fauquier L; Vandel L; Ting JP
    Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16321-6. PubMed ID: 16254053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repression of IFN-gamma induction of class II transactivator: a role for PRDM1/Blimp-1 in regulation of cytokine signaling.
    Tooze RM; Stephenson S; Doody GM
    J Immunol; 2006 Oct; 177(7):4584-93. PubMed ID: 16982896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TGF-beta suppresses IFN-gamma induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression.
    Lee YJ; Han Y; Lu HT; Nguyen V; Qin H; Howe PH; Hocevar BA; Boss JM; Ransohoff RM; Benveniste EN
    J Immunol; 1997 Mar; 158(5):2065-75. PubMed ID: 9036950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of MHC class II antigen expression in trophoblast cells results from a lack of class II transactivator (CIITA) gene expression.
    Murphy SP; Tomasi TB
    Mol Reprod Dev; 1998 Sep; 51(1):1-12. PubMed ID: 9712312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Class II transactivator (CIITA) promoter methylation does not correlate with silencing of CIITA transcription in trophoblasts.
    Holtz R; Choi JC; Petroff MG; Piskurich JF; Murphy SP
    Biol Reprod; 2003 Sep; 69(3):915-24. PubMed ID: 12748124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway.
    Miller DM; Rahill BM; Boss JM; Lairmore MD; Durbin JE; Waldman JW; Sedmak DD
    J Exp Med; 1998 Mar; 187(5):675-83. PubMed ID: 9480977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes.
    Chang CH; Fontes JD; Peterlin M; Flavell RA
    J Exp Med; 1994 Oct; 180(4):1367-74. PubMed ID: 7931070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.